These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25742580)

  • 21. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impulse control disorders and pathological gambling in patients with Parkinson disease.
    Stamey W; Jankovic J
    Neurologist; 2008 Mar; 14(2):89-99. PubMed ID: 18332838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Parkinson's disease--where do we go from here?
    Suchowersky O
    Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605
    [No Abstract]   [Full Text] [Related]  

  • 28. Delusional infestation induced by piribedil add-on in Parkinson's disease.
    Kölle M; Lepping P; Kassubek J; Schönfeldt-Lecuona C; Freudenmann RW
    Pharmacopsychiatry; 2010 Aug; 43(6):240-2. PubMed ID: 20614418
    [No Abstract]   [Full Text] [Related]  

  • 29. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
    Ziegler M; Castro-Caldas A; Del Signore S; Rascol O
    Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological gambling in Parkinson's disease--a review of the literature.
    Djamshidian A; Cardoso F; Grosset D; Bowden-Jones H; Lees AJ
    Mov Disord; 2011 Sep; 26(11):1976-84. PubMed ID: 21661054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine agonist therapy for Parkinson disease and pathological gambling.
    Imamura A; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2006 Dec; 12(8):506-8. PubMed ID: 16723269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?
    Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C
    Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy and Safety of Piribedil Relative to Pramipexole for the Treatment of Early Parkinson Disease: A Systematic Literature Review and Network Meta-Analysis.
    Chen X; Ren C; Li J; Wang S; Dron L; Harari O; Whittington C
    Clin Neuropharmacol; 2020; 43(4):100-106. PubMed ID: 32658035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological gambling in Parkinson's disease.
    Stocchi F
    Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathological gambling induced by dopamine agonists].
    Gahr M; Connemann BJ; Schönfeldt-Lecuona CJ
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):470-4. PubMed ID: 21809260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problematic gambling on dopamine agonists: Not such a rarity.
    Grosset KA; Macphee G; Pal G; Stewart D; Watt A; Davie J; Grosset DG
    Mov Disord; 2006 Dec; 21(12):2206-8. PubMed ID: 17013907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impulse control disorders in Parkinson's disease: a psychosocial perspective.
    Delaney M; Leroi I; Simpson J; Overton PG
    J Clin Psychol Med Settings; 2012 Sep; 19(3):338-46. PubMed ID: 22581074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with the development of impulse compulsive disorders in Parkinson patients.
    Rana AQ; Mansoor W; Hussaini S; Al Mosabbir A; Rahman M; Rahman L
    Int J Neurosci; 2013 Jul; 123(7):503-6. PubMed ID: 23336737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.
    Ray NJ; Miyasaki JM; Zurowski M; Ko JH; Cho SS; Pellecchia G; Antonelli F; Houle S; Lang AE; Strafella AP
    Neurobiol Dis; 2012 Dec; 48(3):519-25. PubMed ID: 22766031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.